{"title":"NEURO(X)","description":"Increase your productivity naturally with a clear mind and steady focus, without the caffeine dependence.","products":[{"product_id":"neurox-cognitive-performance","title":"NEURO(X) - Cognitive Performance","description":"\u003cbody\u003e\n\u003ch3\u003eNEURO(X) is a nootropic and adaptogenic dietary supplement that helps support healthy brain function, increases focus and clarity, and enhances memory recall.\u003cspan data-mce-fragment=\"1\" class=\"oui-sup\"\u003e†\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cmeta name=\"viewport\" content=\"width=device-width, initial-scale=1\"\u003e\n\u003cstyle\u003e\n.accordion {\n  background-color: #ce484f;\n  color: #000;\n  cursor: pointer;\n  padding: 10px;\n  width: 100%;\n  border: solid thin;\n  text-align: left;\n  outline: solid thin;\n  font-size: 16px;\n  transition: 0.7s;\n}\n\n.active, .accordion:hover {\n  background-color: #f2d9d9; \n}\n\n.panel {\n  padding: 0 18px;\n  display: none;\n  background-color: f2d9d9;\n  overflow: hidden;\n}\n\u003c\/style\u003e\n\n\n\n\u003ch2\u003eWhat's Inside?\u003c\/h2\u003e\n\n\n\u003cbutton class=\"accordion\"\u003e💢 CDP-Choline - 250MG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003eIncreased attention \u0026amp; focus ⬆\u003c\/li\u003e\n  \u003cli\u003eEnhances memory recall ⬆\u003c\/li\u003e\n  \u003cli\u003ePrevents cognitive decline ⬇\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eCDP-choline (citicoline) is a nootropic compound with high bioavailability which is readily converted in the brain to the learning neurotransmitter, acetylcholine. \u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/citicoline\"\u003eRead more about CDP-Choline!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Improved attentional performance following citicoline administration in healthy adult women. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study assessed the potential cognitive-enhancing efects of cticoline as dietary supplement in 60 healthy adult women in a double-blind, randomized, placebo-controlled study. \u003c\/li\u003e\n  \u003cli\u003eThe subjects were divided into three experimental groups; a daily oral dose of 250 mg Citicoline, 500 mg citicoline, or placebo for 28 days.. \u003c\/li\u003e\n  \u003cli\u003eEvaluation was done by Continuous Performance Test II (CPT-II), a measure sensitive to attentional function.. \u003c\/li\u003e\n  \u003cli\u003eThe results afyter 28 days showed that individuals on the 250 mg dose of citicoline made fewer omission and commission errors compared to those in the placebo and the 500 mg group! These subjects were able to produce more correct responses on the CPT-II, likely due to improved cognitive inhibition. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/improved_attentional_performance_following_citicoline_administration_in_healthy_adult_women.png?v=1652114349\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eE. McGlade, A. Locatelli, J. Hardy, T. Kamiya, M. Morita, K. Morishita, Y. Sugimura and D. Yurgelun-Todd, Food and Nutrition Sciences, Vol. 3 No. 6, 2012, pp. 769-773. doi: 10.4236\/fns.2012.36103. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.scirp.org\/journal\/paperinformation.aspx?paperid=19921\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThe objective of this study was to investigate the effects of citicoline on memory in healthy elderly with age-associated memory impairment. \u003c\/li\u003e\n  \u003cli\u003e100 healthy men and women participated in this randomized, double-blind, placebo-controlled trial. \u003c\/li\u003e\n  \u003cli\u003eThe subjects received a daily dose of either 500 mg citicoline or placebo for 12 weeks, and memory function was assessed at baseline and at the end of the intervention using computerized tests.. \u003c\/li\u003e\n  \u003cli\u003eSubjects using citicoline showed significantly greater improvements in memory performance, especially episodic memory. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Citicoline_and_Memory_Function_in_Healthy_Older_Adults-_A_Randomized_Double-Blind_Placebo-Controlled_Clinical_Trial.png?v=1652114990\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eEri Nakazaki, Eunice Mah, Kristen Sanoshy, Danielle Citrolo, Fumiko Watanabe, The Journal of Nutrition, Volume 151, Issue 8, August 2021, Pages 2153–2160, https:\/\/doi.org\/10.1093\/jn\/nxab119\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/academic.oup.com\/jn\/article\/151\/8\/2153\/6274469\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e💢 Red Panax Ginseng - 200MG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003eImproved cognition \u0026amp; reaction time ⬆\u003c\/li\u003e\n  \u003cli\u003eAttenuated spikes in blood glucose caused by high stress response ⬇\u003c\/li\u003e\n  \u003cli\u003eIncreased subjective well-being ⬆\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eRed Panax Ginseng is a plant root with a long history of traditional medicine containing high levels of ginsenosides. These exhibit a large variety of pharmacological effects including neuroprotection and treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/red-panax-ginseng\"\u003eRead more about Red Panax Ginseng!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study examined the effects of a single dose of Panax ginseng on cognitive performance in 30 healthy adult volunteers in a double-bline, placebo-controlled study.. \u003c\/li\u003e\n  \u003cli\u003eThe subjects were givn either 200 mg or 400 mg of Panax ginseng, or a placebo. \u003c\/li\u003e\n  \u003cli\u003eThe subjects completed a 10 minute test battery at baseline, and then six times in immediate sucession starting 1 hour after supplementation. \u003c\/li\u003e\n  \u003cli\u003eThe tests inclused a Serial Threes suntraction task, a Serial Sevens task, a Rapid Visual Information Processing task, and a \"mental fatigue\" visual analogue scale. Blood glucose was also measured. \u003c\/li\u003e\n  \u003cli\u003eSubjects given the 200 mg dose of Panaxi ginseng had the most significant improvements in the Serial Sevens subtraction task and reduction of subjective mental fatigue. Both doses of Panax ginseng resuced the subjects' blood glucose levels.\u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Single_doses_of_Panax_ginseng_G115_reduce_blood_glucose_levels_and_improve_cognitive_performance_during_sustained_mental_activity.png?v=1652118223\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eReay JL, Kennedy DO, Scholey AB. J Psychopharmacol. 2005 Jul;19(4):357-65. doi: 10.1177\/0269881105053286.  \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881105053286\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained 'mentally demanding' tasks.  \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThe goal of this study was to examine relationship between elicit cognitive improvements and lower blood glucose levels caused by single doses of Panax ginseng. \u003c\/li\u003e\n  \u003cli\u003e27 healthy young adults were examined in this double-bline, placebo-controlled study. The subjects completed a 10 minute \"cognitive demand\" test battery at baseline, then consumed capsules containing either 200 mg Ginseng or placebo, and 30 minutes later consumed a drink containing either 25 g glucose or placebo. Another 30 mnutes later, the subjects completed the \"cognitive demand\" battery six times in immediate succession.\u003c\/li\u003e\n  \u003cli\u003eThe 10 minute “cognitive demand” battery comprised a Serial Threes subtraction task, a Serial Sevens subtraction task, a Rapid Visual Information Processing task, and a “mental fatigue” visual analogue scale. Blood glucose levels weree also measured before and after completions of the battery. \u003c\/li\u003e\n  \u003cli\u003eThe results showed that both Panax Ginseng and glucose were able to enhance the performance of mental erithmetic tasks and reduced the subjective feelings of fatigue during the sustained tests. There was no evidence of any synergistic relationship between Panax ginseng and exogenous glucose ingestion. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Effects_of_Panax_ginseng_consumed_with_and_without_glucose_on_blood_glucose_levels_and_cognitive_performance_during_sustained_mentally_demanding_tasks..png?v=1652119306\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eReay JL, Kennedy DO, Scholey AB. J Psychopharmacol. 2006 Nov;20(6):771-81. doi: 10.1177\/0269881106061516. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881106061516\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e💢 Phophatidylserine - 150MG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003eImproved cognition ⬆\u003c\/li\u003e\n  \u003cli\u003ePrevents cognitive decline ⬇\u003c\/li\u003e\n  \u003cli\u003eReduced symptoms of attention-decicit\/hyperactivity disorder (ADHD) ⬇\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eThis nootropic compound is a fat-soluble amino acid derivative found in high amounts in the brain. Supplementation of phosphatidylserine contributes to the formation and maintenance of healthy cellular membranes.\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/phosphatidylserine\"\u003eRead more about Phosphatidylserine!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThe purpose of this study was to investigate the effects of a phosphatidylserine-containing formulation on cognitive function before and after intense resistence exercise. \u003c\/li\u003e\n  \u003cli\u003e18 trained college-aged males ingested 400 mg of soy-derived phosphatidylserine (PS) in a suplement called IQPLUS, or placebo for 14 days in a randomized, double-blined, placebo-controlled trial. \u003c\/li\u003e\n  \u003cli\u003eAfter 14 days of supplementation, the subjects performed an acute bout of lower body resistance training. A cognitive function test in the form of Serial Subtraction Test (SST) was measured prior to exercise, 5 minutes after, and again 60 minutes after. \u003c\/li\u003e\n  \u003cli\u003eThe group supplementing with Phosphatidylserine had significant improvements in the cognitive function test before training, including a 20% reduction in time needed for a correct calculation, a 39% reduction in the total number of errors, and a 13% increase in the number of correct calculations.\u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/The_effects_of_IQPLUS_Focus_on_cognitive_function_mood_and_endocrine_response_before_and_following_acute_exercise.png?v=1652120164\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eParker AG, Gordon J, Thornton A, Byars A, Lubker J, Bartlett M, Byrd M, Oliver J, Simbo S, Rasmussen C, Greenwood M, Kreider RB. J Int Soc Sports Nutr. 2011 Oct 21;8:16. doi: 10.1186\/1550-2783-8-16.  \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1186\/1550-2783-8-16\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study examined the effects of phosphatidylserine supplementation on cognitive function of elderly Japanese subjects with memory complaints. \u003c\/li\u003e\n  \u003cli\u003e78 subjects were randomly assigned in this double-blind, placebo-controlled trial to take wither 100 mg or 300 mg Phosphatidylserine (PS) or placebo daily for 6 months. \u003c\/li\u003e\n  \u003cli\u003eThe subjects were tested before and after the 6-month trial by RBMT which is a standardized and validated test for memory functions, and by DWR where a sunject is presented with 3 unrelated words and is later asked to recall them. \u003c\/li\u003e\n  \u003cli\u003eSubjects in the 100 mg phosphatidylserine group had the most significant improvements in the cognitive performance tests, especially those who were categorized in the low-score subgroup at the beginning of the trial.  \u003c\/li\u003e\n  \u003cli\u003eSubjects in the 100 mg phosphatidylserine group also showed memory improvments which were mostly attributed to the increase in delayed verbal recall, a memory ability attenuated in the earliest stages of dementia.\u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Soybean-derived_phosphatidylserine_improves_memory_function_of_the_elderly_Japanese_subjects_with_memory_complaints..png?v=1652121542\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eKato-Kataoka A, Sakai M, Ebina R, Nonaka C, Asano T, Miyamori T. J Clin Biochem Nutr. 2010 Nov;47(3):246-55. doi: 10.3164\/jcbn.10-62. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/47\/3\/47_10-62\/_article\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study investigated whether supplementation of phosphatidylserine, the naturally-occuring phospholipid, could improve ADHD symptoms in children. \u003c\/li\u003e\n  \u003cli\u003e36 children with symptoms of ADHD, but no prior drug treatment were given either 200 mg PS or placebo daily for 2 months in a randomised, double-blind, placebo-controlled manner.\u003c\/li\u003e\n  \u003cli\u003eStudy measures included ADHD symptoms based on DSM-IV-TR, short-term auditory memory and working memory using the Digit Span Test of the Wechsler Intelligence Scal for Children, and mental performance to visual stimuli (GO\/NO GO task). \u003c\/li\u003e\n  \u003cli\u003ePhosphatidylserine supplementation had significant improvements in AHDH symptoms, short-term auditory memory, and inattention and impulsivity. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/The_effect_of_phosphatidylserine_administration_on_memory_and_symptoms_of_attention-deficit_hyperactivity_disorder.png?v=1652122394\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eHirayama S, Terasawa K, Rabeler R, Hirayama T, Inoue T, Tatsumi Y, Purpura M, Jäger R. J Hum Nutr Diet. 2014 Apr;27 Suppl 2:284-91. doi: 10.1111\/jhn.12090. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jhn.12090\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e💢 Huperzine A - 100MCG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003eIncreased cognition ⬆\u003c\/li\u003e\n  \u003cli\u003ePrevents cognitive decline ⬇\u003c\/li\u003e\n  \u003cli\u003eIncreased attention and focus ⬆\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eHuperzine A is a nootropic compound derived from the ancient chinese herb, Huperzia serrata, which promotes the expression of the learning neurotransmitter acetylcholine. It does this by inhibiting acetylcholine esterase, an enzyme which breaks down and degrades acetylcholine.\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/huperzine-a\"\u003eRead more about Huperzine A!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine\u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis comprehensive review underlines key research findings regarding Huperzine A supplementation ranging from biochemical mechanism of action, cellular and pharmacokinetic effects in model organisms, and phase IV clinical trials in humans. \u003c\/li\u003e\n  \u003cli\u003eANNOTATION. \u003c\/li\u003e  \n  \u003cli\u003eCompared with the common medications available to treat Alzheimer's diseases (tacrine, donepezil, and rivastigmine), HupA has better penetration through the blood-brain barrier, higher oral bioavailability, and longer duration of AChE inhibitory action. \u003c\/li\u003e\n  \u003cli\u003eHupA has been found to improve cognitive deficits in a broad range of animal models including rodents and primates. \u003c\/li\u003e\n  \u003cli\u003ePharmacokinetic studies in rodents, canines, and healthy human volunteers indicated that HupA was absorbed rapidly, distributed widely in the body, and eliminated at a moderate rate with the property of slow and prolonged release after oral administration. \u003c\/li\u003e\n  \u003cli\u003eAnimal and clinical safety tests showed that HupA had no unexpected toxicity. \u003c\/li\u003e\n  \u003cli\u003eThe phase IV clinical trials in China have demonstrated that HupA significantly improved memory deficits in elderly people with benign senescent forgetfulness, and patients with Alzheimer disease and vascular dementia, with minimal peripheral cholinergic side effects and no unexpected toxicity. \u003c\/li\u003e  \n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Progress_in_studies_of_huperzine_A_a_natural_cholinesterase_inhibitor.png?v=1652156206\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eWang R, Yan H, Tang XC. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin. 2006 Jan;27(1):1-26. doi: 10.1111\/j.1745-7254.2006.00255.x. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.nature.com\/articles\/aps20061\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Huperzine A promotes hippocampal neurogenesis in vitro and in vivo \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study showed that Hup A not only promoted the proliferation of cultured mouse embryonic hippocampal neural stem cells (NSCs), but also increased the newly generated cells in the subgranular zone (SGZ) of the hippocampus in adult mice. \u003c\/li\u003e\n  \u003cli\u003eAdministration of Hup A to adult mice significantly enhanced the cell proliferation in dentate gyrus of hippocampus, and increased the remaining newborn cells 4 weeks after the drug administration. \u003c\/li\u003e\n  \u003cli\u003eNewly generated BrdUþ\/NeuNþ neurons were also increased by Hup A treatment.\u003c\/li\u003e\n  \u003cli\u003eThese findings suggest a novel role of Hup A in neurogenesis and provide a new insight into its therapeutic effects in neurological disorders via a neurogenesis-related mechanism. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Huperzine_A_promotes_hippocampal_neurogenesis_in_vitro_and_in_vivo.png?v=1652156634\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eMa T, Gong K, Yan Y, Zhang L, Tang P, Zhang X, Gong Y. Brain Res. 2013 Apr 19;1506:35-43. doi: 10.1016\/j.brainres.2013.02.026.  \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"sciencedirect.com\/science\/article\/pii\/S0006899313002618\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e💢 Rhodiola Rosea - 400MG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003eReduced fatigue under acute stress ⬇\u003c\/li\u003e\n  \u003cli\u003eIncreased cognition ⬆\u003c\/li\u003e\n  \u003cli\u003eIncreased subjective well-being ⬆\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eRhodiola rosea is a popular adaptogenic herb which has been used to help reduce fatigue under stressful situations. \u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/rhodiola-rosea\"\u003eRead more about Rhodiola Rosea!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study examined the effects of a single dose of Rhodiola rosea extract on capacity for mental work against a background of fatigue and stress. \u003c\/li\u003e\n  \u003cli\u003e161 cadets aged 19 to 21 years old were used as subjects in a randomised, double-blind, placebo-controlled manner. \u003c\/li\u003e\n  \u003cli\u003eThe subjects were given either 370 mg or 555 mg Rhodiola rosea, placebo, or no treatment for 5 days while performing regular military night duties. \u003c\/li\u003e\n  \u003cli\u003eThe study showed a pronounced antifatigue effect reflected in an antifatigue index, with no difference between the two doses of Rhodiola Rosea. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/A_randomized_trial_of_two_different_doses_of_a_SHR-5_Rhodiola_rosea_extract_versus_placebo_and_control_of_capacity_for_mental_work.png?v=1652123385\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eShevtsov VA, Zholus BI, Shervarly VI, Vol'skij VB, Korovin YP, Khristich MP, Roslyakova NA, Wikman G. Phytomedicine. 2003 Mar;10(2-3):95-105. doi: 10.1078\/094471103321659780. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0944711304702007?via%3Dihub\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms.\u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study aimed to explore the clinical outcomes in burnout patients treated with Rhodiola rosea in an exploratory, noncontrolled manner. \u003c\/li\u003e\n  \u003cli\u003e118 patients experiencing burnout were given a 400 mg dose of Rhodiola rosea daily for 12 weeks and tested for a wide range of rating scales to provide a basis for the planning of sunsequent studies. \u003c\/li\u003e\n  \u003cli\u003eClinical assessments included the Maslach Burnout Inventory, Burnout Screening Scales I and II, Sheehan Disability Scale, Perceived Stress Questionnaire, Number Connection Test, Multidimensional Mood State Questionnaire, Numerical Analogue Scales for different stress symptoms and impairment of sexual life, Patient Sexual Function Questionnaire, and the Clinical Global Impression Scales. \u003c\/li\u003e\n  \u003cli\u003eThe results showed a clear improvement across the board over time with Rhodiola rosea supplementation. The most significant improvements were seen within the first week of supplementation. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Multicenter_open-label_exploratory_clinical_trial_with_Rhodiola_rosea_extract_in_patients_suffering_from_burnout_symptoms..jpg?v=1652123846\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eKasper S, Dienel A. Neuropsychiatr Dis Treat. 2017 Mar 22;13:889-898. doi: 10.2147\/NDT.S120113. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.dovepress.com\/multicenter-open-label-exploratory-clinical-trial-with-rhodiola-rosea--peer-reviewed-fulltext-article-NDT\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study examined the effects of 400 mg Rhodiola rosea supplementation in 100 subjects with prolonged or chronic fatigue symptoms in an uncontrolled, open-label multicenter clinical trial. \u003c\/li\u003e\n  \u003cli\u003eThe subjects were administered 2 x 200 mg Rhodiola rosea daily for 8 weeks. \u003c\/li\u003e\n  \u003cli\u003eOutcome measures were scales and tests related to fatigue. \u003c\/li\u003e\n  \u003cli\u003eThe results showed significant improvement in all all the fatigue indexes over the 8 week trial, with the most significant improvement after one week. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Rhodiola_rosea_in_Subjects_with_Prolonged_or_Chronic_Fatigue_Symptoms.png?v=1652124290\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eLekomtseva Y, Zhukova I, Wacker A. Complement Med Res. 2017;24(1):46-52. doi: 10.1159\/000457918. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.karger.com\/Article\/FullText\/457918\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 The Effect of Acute Rhodiola rosea Ingestion on Exercise Heart Rate, Substrate Utilisation, Mood State, and Perceptions of Exertion, Arousal, and Pleasure\/Displeasure in Active Men.  \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThe aim of this study was to examine the effect of acute Rhodiola rosea ingestion on substrate utilisation, mood state, RPE, and exercise affect in a random, double-blind, placebo-controlled study. \u003c\/li\u003e\n  \u003cli\u003eSubjects were 10 active males given either 3 mg\/kg Rhodiola rosea (210 mg for 150 lbs person) or placebo before completing two 30-minute cycling trials and an intensity of 70% VO2 max. \u003c\/li\u003e\n  \u003cli\u003eSubjects were tested for mood state and exercise affect before, during, and after exercise. \u003c\/li\u003e\n  \u003cli\u003eThe results show that Rhodiola rosea was effective in significantly reducing the rating of perceived exertion over time during exercise, and also significantly improved the feeling of pleasure after exercise. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/The_Effect_of_Acute_Rhodiola_rosea_Ingestion_on_Exercise_Heart_Rate_Substrate_Utilisation_Mood_State_and_Perceptions_of_Exertion_Arousal_and_Pleasureispleasure_in_Active_Men.png?v=1652124468\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eDuncan MJ, Clarke ND. J Sports Med (Hindawi Publ Corp). 2014;2014:563043. doi: 10.1155\/2014\/563043.  \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.hindawi.com\/journals\/jsm\/2014\/563043\/\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e💢 Bacopa Monnieri - 300MG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003eIncreased memory \u0026amp; working memory ⬆\u003c\/li\u003e\n  \u003cli\u003eIncreased attention ⬆\u003c\/li\u003e\n  \u003cli\u003eIncreased cognitive processing efficiency ⬆\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eBacopa monnieri is a nootropic herb which has been used in traditional medicine for longevity and cognitive enhancement. Based on the available research, bacopa may work by decreasing levels of acetylcholine esterase, an inhibitor of the learning neurotransmitter acetylcholine.\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/bacopa-monnieri\"\u003eRead more about Bacopa Monnieri!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.  \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThe aim of this study was to evaluate the effects of Bacopa monnieri on cognitive function an affect, and its safety and tolerability in 54 healthy elderly study participants. \u003c\/li\u003e\n  \u003cli\u003e48 participants completed this randomised, double-blind, placebo-controlled study with a 6-week placebo run-in period followed by 12 weeks of treatment with 300 mg Bacopa monnieri daily or placebo. \u003c\/li\u003e\n  \u003cli\u003eMeasured outcomes included the delayed recall score from the Rey Auditory Verbal Learning Test (AVLT), the Stroop Task assessing the ability to ignore irrelevant information, the Divided Attention Task (DAT), the Wechsler Adult Intelligence Scale (WAIS) letter-digit test of immediate working memory State-Trait Anxiety Inventory, Center for Epidemiologic Studies Depression scale (CESD)-10 depression scale, and the Profile of Mood States. \u003c\/li\u003e\n  \u003cli\u003eBacopa participants had enhanced AVLT delayed word recall memory scores relative to placebo, and the Bacopa group improved on the Stroop task, although the changes were insignificant. CESD-10 depression scores, combined state plus trait anxiety scores, and heart rate decreased over time for the Bacopa group but increased for the placebo group. \u003c\/li\u003e\n  \u003cli\u003eBacopa participants reported no negative side-effects, and the dose of 300 mg was well tolerated. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Effects_of_a_standardized_Bacopa_monnieri_extract_on_cognitive_performance_anxiety_and_depression_in_the_elderly.png?v=1652125011\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eCalabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. J Altern Complement Med. 2008 Jul;14(6):707-13. doi: 10.1089\/acm.2008.0018. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.liebertpub.com\/doi\/10.1089\/acm.2008.0018\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Effects of 12-Week Bacopa monnieri Consumption on Attention, Cognitive Processing, Working Memory, and Functions of Both Cholinergic and Monoaminergic Systems in Healthy Elderly Volunteers. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study aimed to determine the effect of B. monnieri on attention, cognitive processing, working memory, and cholinergic and monoaminergic functions in healthy elderly. \u003c\/li\u003e\n  \u003cli\u003eA randomized double-blind placebo-controlled design was utilized on 60 healthy elderly subjects receiving either 300 mg or 600 mg Bacopa monnieri or a placebo once daily for 12 weeks. \u003c\/li\u003e\n  \u003cli\u003eThe cholinergic and monoaminergic systems functions were determined using AChE and MAO activities. Working memory was assessed using percent accuracy and reaction time of various memory tests as indices, whereas attention and cognitive processing were assessed using latencies and amplitude of N100 and P300 components of event-related potential. All assessments were performed before treatment, every four weeks throughout study period, and at four weeks after the study. \u003c\/li\u003e\n  \u003cli\u003eThe results show Bacopa monnieri treatment improved working memory and decreased latencies, while suppressing the Acetylcholine Esterase activity. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Effects_of_12-Week_Bacopa_monnieri_Consumption_on_Attention_Cognitive_Processing_Working_Memory_and_Functions_of_Both_Cholinergic_and_Monoaminergic_Systems_in_Healthy_Elderly_Voluntee.png?v=1652129499\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003ePeth-Nui T, Wattanathorn J, Muchimapura S, Tong-Un T, Piyavhatkul N, Rangseekajee P, Ingkaninan K, Vittaya-Areekul S. Evid Based Complement Alternat Med. 2012;2012:606424. doi: 10.1155\/2012\/606424. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.hindawi.com\/journals\/ecam\/2012\/606424\/\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e💢 Ginkgo Biloba - 160MG \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n\n\u003ch3\u003ePerformance Breakdown:\u003c\/h3\u003e\n \u003cul\u003e\n  \u003cli\u003ePrevents cognitive decline ⬇\u003c\/li\u003e\n  \u003cli\u003eIncreased memory recall ⬆\u003c\/li\u003e\n  \u003cli\u003eIncreased processing speed \u0026amp; accuracy ⬆\u003c\/li\u003e\n  \u003cli\u003eReduced symptoms associated with attention-deficit\/hyperactivity disorder (ADHD) ⬇\u003c\/li\u003e\n\u003c\/ul\u003e  \n \n \u003ch3\u003eMechanism of Action:\u003c\/h3\u003e\n  \u003cul\u003e\n  \u003cli\u003eGinkgo Biloba is the most commonly ingested herb for brain health and support. This nootropic plant compound is most commonly used to prevent the natural process of cognitive decline. \u003c\/li\u003e\n\u003c\/ul\u003e  \n \n\u003cp\u003e\u003ca href=\"https:\/\/destinyformulations.com\/pages\/ginkgo-biloba\"\u003eRead more about Ginkgo Biloba!\u003c\/a\u003e\u003c\/p\u003e\n\n\u003ch3\u003eAnnotated References:\u003c\/h3\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study aimed to assess the efficacy of a 240 mg once-daily preparation of Ginkgo biloba extract in 404 outpatients ≥ 50 years old diagnosed with mild to moderate dementia, Alzheimer’s disease, or vascular dementia. \u003c\/li\u003e\n  \u003cli\u003eGinkgo biloba (EGb 761®) improved cognitive functioning, neuropsychiatric symptoms and functional abilities in both types of dementia. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Efficacy_and_tolerability_of_a_once_daily_formulation_of_Ginkgo_biloba_extract_EGb_761_in_Alzheimer_s_disease_and_vascular_dementia.png?v=1652130065\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eIhl R, Tribanek M, Bachinskaya N; GOTADAY Study Group. Pharmacopsychiatry. 2012 Mar;45(2):41-6. doi: 10.1055\/s-0031-1291217. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/10.1055\/s-0031-1291217\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study employed a double-blind, randomised, placebo-controlled, 24-week trial with 410 outpatients to demonstrate efficacy and safety of a 240 mg once-daily formulation of Ginkgo biloba extract EGb 761® in patients with mild to moderate dementia associated with neuropsychiatric symptoms. \u003c\/li\u003e\n  \u003cli\u003ePrimary outcomes were the changes from baseline to week 24 in the SKT and NPI total scores. \u003c\/li\u003e\n  \u003cli\u003eThe ADCS Clinical Global Impression of Change (ADCS-CGIC), Verbal Fluency Test, Activities of Daily Living International Scale (ADL-IS), DEMQOL-Proxy quality-of-life scale and 11-point box scales for tinnitus and dizziness were secondary outcome measures.  \u003c\/li\u003e\n  \u003cli\u003ePatients supplementing with Ginkgo biloba showed improvements clinically relevant improvement in cognition, psychopathology, functional measures, and quality of life. \u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Ginkgo_biloba_extract_EGb_761_in_dementia_with_neuropsychiatric_feature.png?v=1652130459\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003e•\tHerrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. J Psychiatr Res. 2012 Jun;46(6):716-23. doi: 10.1016\/j.jpsychires.2012.03.003. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0022395612000854?via%3Dihub\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThe aim of this study was to investigate the effects of EGb 761 on memory and the specificity of such effects on distinct memory functions in middle-aged healthy volunteers. \u003c\/li\u003e\n  \u003cli\u003eA total of 188 healthy subjects aged 45–56 years were randomised to receive EGb 761 (240 mg once daily) or placebo for 6 weeks. \u003c\/li\u003e\n  \u003cli\u003eOutcome measures were the change in memory performance in a demanding standardised free recall paradigm and a less demanding standardised recognition test. \u003c\/li\u003e\n  \u003cli\u003eEGb 761-treated subjects improved significantly in quantity of recall. Other test improvements were statistically insignificant.\u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Specific_memory_effects_of_Ginkgo_biloba_extract_EGb_761_in_middle-aged_healthy_volunteers.png?v=1652130557\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eKaschel R. Phytomedicine. 2011 Nov 15;18(14):1202-7. doi: 10.1016\/j.phymed.2011.06.021.  \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0944711311002273?via%3Dihub\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cbutton class=\"accordion\"\u003e📃 Ginkgo biloba for attention-deficit\/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. \u003c\/button\u003e\n\u003cdiv class=\"panel\"\u003e\n  \n \u003cul\u003e\n  \u003cli\u003eThis study examined whether Ginkgo biloba would be beneficial for treatment of ADHD by using a double blind, randomized, parallel group comparison of Ginkgo biloba and methylphenidate (ritalin). \u003c\/li\u003e\n  \u003cli\u003eFifty outpatients (39 boys and 11 girls) with a DSM-IV-TR diagnosis of ADHD were study population of this trial. \u003c\/li\u003e\n  \u003cli\u003eThe subjects were treated with 80-120 mg Ginkgo biloba daily for 6 weeks, or 20-30 mg of methylphenidate for comparison. Doses ranged based on the patients' weights. \u003c\/li\u003e\n  \u003cli\u003eThe principal measure of outcome was the Teacher and Parent ADHD Rating Scale- IV. Asessments were done at baseline and at 21 and 42 days after the medication started. \u003c\/li\u003e\n  \u003cli\u003eTreatment with Ginkgo biloba was associated with reduced symptoms of ADHD as assessed by parental and teacher assessment, although the effects were significantly lesser than the reference drug methylphenidate.\u003c\/li\u003e\n\u003c\/ul\u003e \n\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/files\/Ginkgo_biloba_for_attention-deficit_hyperactivity_disorder_in_children_and_adolescents.png?v=1652131228\" width=\"100%\" height=\"100%\"\u003e\n\n\u003cp\u003eSalehi B, Imani R, Mohammadi MR, Fallah J, Mohammadi M, Ghanizadeh A, Tasviechi AA, Vossoughi A, Rezazadeh SA, Akhondzadeh S. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76-80. doi: 10.1016\/j.pnpbp.2009.09.026. \u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0278584609003261?via%3Dihub\" target=\"_blank\"\u003eRead the full study here!\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\n\u003cscript\u003e\nvar acc = document.getElementsByClassName(\"accordion\");\nvar i;\n\nfor (i = 0; i \u003c acc.length; i++) {\n  acc[i].addEventListener(\"click\", function() {\n    this.classList.toggle(\"active\");\n    var panel = this.nextElementSibling;\n    if (panel.style.display === \"block\") {\n      panel.style.display = \"none\";\n    } else {\n      panel.style.display = \"block\";\n    }\n  });\n}\n\n\n\n\n\u003c\/script\u003e\n\n\n\u003c\/body\u003e","brand":"Destiny Formulations","offers":[{"title":"Default Title","offer_id":39679978569822,"sku":"","price":42.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/products\/NEUROBottleFront.png?v=1650386901"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0016\/9882\/4286\/collections\/NEURO_Title_Cognitive_Performance.png?v=1651639659","url":"https:\/\/destiny-formulations.myshopify.com\/collections\/neurox.oembed","provider":"Destiny Formulations","version":"1.0","type":"link"}